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Abstract 
In the United States approximately 10–15% of women consume alcohol (ethanol) 
during pregnancy. Even low amounts of ethanol consumption during pregnancy can elicit 
long-term consequences. Prenatal experience with as few as 3 drinks has been 
associated with increase problem drinking in adulthood. Such effects are corroborated in 
rodents; however, the underlying neural adaptations contributing to this effect are not 
clear. In the current set of experiments, we investigated whether changes in ethanol 
responding following prenatal ethanol exposure involved kappa opioid receptor 
activation and expression.  
Sprague-Dawley rats were prenatally exposed to low levels of alcohol (1.0 g/kg) 
during late gestation (gestational day 17-20: GD17-20) via intragastric intubation of 
pregnant dams. Following birth, ethanol intake, kappa and mu opioid-induced place 
conditioning, and kappa opioid receptor expression in mesolimbic brain regions was 
assessed in infant rats (postnatal day 14-15: PD14-15) that were offspring of dams given 
ethanol, vehicle, or untreated, during pregnancy.  
Animals exposed to prenatal alcohol drank more alcohol later in life 
and exhibited significant changes in the kappa opioid system.  While control subjects 
found kappa opioid activation aversive, animals exposed to ethanol prenatally exhibited 
either no aversion or appetitive responding. Further analysis revealed that synaptosomal 
kappa opioid receptor expression was significantly decreased in brain areas implicated 
in responding to ethanol. Overall, this data suggests that prenatal ethanol affects kappa 
opioid function and expression and that these changes may be involved in increased 
drinking later in life.
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1. Introduction 
Alcohol abuse is a worldwide concern affecting the lives of millions. While a large 
portion of the population drinks with little to no adverse consequences, a substantial 
number become dependent and abuse the drug with extremely adverse outcomes. 
Experience with alcohol in the womb or during infancy has been show to predispose 
individuals to problematic alcohol consumption later in life. Epidemiological studies 
confirm that humans exposed prenatally to a moderate amount of ethanol are at risk for 
alcohol abuse as adolescents and subsequently as adults (Alati et al., 2006, 2008; Baer 
et al., 1998, 2003; Yates et al., 1998).  
Preclinical studies seem to confirm these epidemiological results. For example, 
studies have shown that rats exposed to 1.0 or 2.0 g/kg ethanol on gestational days 17 – 
20 (GD 17 – 20) exhibit enhanced ethanol intake in mid-infancy and adolescence (Arias 
& Chotro 2005; Chotro et al., 2007; Chotro & Arias 2003; Molina et al., 1999; Fabio et 
al., 2013) and learn conditioned preferences for doses of ethanol that untreated animals 
do not find reinforcing (Nizhnikov et al., 2006; Pautassi et al., 2012). Specifically, 
prenatal exposure to ethanol (1 or 2 g/kg IG from G17 – 20) increases the range of 
ethanol doses that 3-hour-old and 14 day-old rat pups find reinforcing in comparison to 
untreated or water exposed controls (Nizhnikov et al., 2006, Pautassi et al., 2012). 
A possible mechanism by which these effect might occur has been discussed by 
Abate and coworkers (2001, 2004). Their studies revealed that prenatal ethanol 
exposure can result in associative learning between the orosensory and the 
postabsorptive, reinforcing effects of ethanol. Later re-exposure to the taste or odor of 
ethanol may trigger drug seeking and intake. Fabio et al. (2013) found that adolescent 
rats that had been exposed to ethanol during late gestation exhibited reduced baseline 
levels of c-fos activation in the prefrontal prelimbic area, an area involved in the 
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extinction of learned associations. The mechanisms underlying this facilitative effect of 
prenatal ethanol on later ethanol intake remain however, largely unknown.   
The endogenous opioid system plays a major role in ethanol reinforcement (Herz 
1997; Vengeliene et al., 2008; Sommer et al., 2006; Méndez & Morales-Mulia 2008). 
General blockade of the opioid system by administration of naltrexone disrupts ethanol 
intake and reinforcement in selected and unselected strains of rats and other species 
(Stromberg et al., 1998; Goodwin et al., 2001; Kato 2008; Nizhnikov et al., 2009; Barson 
et al., 2010), which has led to its application in treatment of alcoholism (Kranzler & Van 
Kirk 2001; Pettinati & Rabinowitz 2006). Antagonism of mu and delta opioid systems 
also inhibits both ethanol intake and reinforcement in adult and infant rats (Barson et al., 
2010; Hyytiä & Kiianmaa 2001; Lindholm et al., 2001; Mitchell et al., 2005 Nizhnikov et 
al., 2009; Pautassi et al., 2011). Moreover, administration of the general opioid 
antagonist naloxone to the pregnant, intoxicated dam inhibits the facilitative effect of 
prenatal ethanol on subsequent ethanol intake (Miranda-Morales et al., 2010).  
The kappa opioid system has also been implicated in ethanol’s motivational 
effects. Generally, kappa opioid receptors are present throughout the central nervous 
system (Atalli et al., 1990;  Leslie & Loughlin, 1992, 1993; Petrillo et al., 1987). Unlike 
the mu and delta opioid system, kappa activity appears to mediate the aversive 
properties of alcohol during infancy and adulthood in non-dependant rats (Land et al., 
2009; Pillai et al., 1986; Pohorecky et al., 1989). For example, 14-day old rats found 
ethanol reinforcing, when assessed in conditioned place or taste preference, only after 
blockade of kappa opioid receptors (Pautassi et al., 2012b). Furthermore, selective 
kappa agonists attenuate ethanol intake in adult non-dependant rats while antagonists 
increase it (Mitchell et al., 2005; Logrip et al., 2009; Sandi et al., 1988; Matsuzawa et al., 
1999; Jamensky & Gianoulakis 1997). Intriguingly, animals which have been made 
ethanol dependant show the reverse response to kappa opioid manipulations, i.e. kappa 
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antagonists reduce operant responding for and intake of ethanol (Walker & Koob 2008; 
Walker et al., 2011; Philpot et al., 2003). This is most likely due to an up-regulation of the 
kappa opioid system resulting in increased responding for ethanol’s negative reinforcing 
properties, with this effect being reversed by kappa opioid antagonists. Kappa opioid 
receptors are positioned pre-synaptically and tend to tonically inhibit dopamine release 
in the nucleus accumbens and in the prefrontal cortex via connections to the ventral 
tegmental area (see Sunil et al., 2012 for comprehensive review). Thus, changes in the 
function of this system (up-regulation) in dependent rats would explain their increased 
drinking and the effects of kappa opioid antagonism in these subjects. The above results 
are examples of a change in the endogenous opioid system due to experience with 
ethanol resulting in increased seeking and drinking of ethanol. 
 
Experiments have shown changes in several opioid systems including the kappa 
opioid system after ethanol exposure in adulthood (Rosin et al., 1999; Turchan et al., 
1999; Lindholm et al., 2000; Cowen & Lawrence 2001; Zapata & Shippenberg 2006; 
Sirohi et al., 2012). For example, Rosin and colleagues (1999) reported down regulation 
of kappa opioid receptor mRNA in the ventral tegmental area (VTA) and nucleus 
accumbens (NAc). On the other hand Lindholm et al., (2000) found an upregulation of 
Dynorphin-B in the NAc. These results suggest that the function of the kappa opioid 
system may change after chronic ethanol exposure during adulthood. We hypothesize 
that similar changes may occur after prenatal exposure to ethanol resulting in increased 
intake of and reinforcement to ethanol later in life, increasing the likelihood of alcohol 
dependence. This possibility is especially intriguing given kappa’s ontogenetic change in 
motivational properties (from appetitive to aversive) during the 1st and 2nd postnatal 
weeks (Barr GA 1993; Petrov et al., 2006; Bals-Kubik et al., 1993; Varlinskaya et al., 
1996). Specifically, Petrov et al., (2006) reported that newborn infant rats find kappa 
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opioid receptor activation appetitive while adults have been shown to clearly find 
activation of kappa aversive. 
The present study analyzed ethanol intake in preweanling rats following brief 
prenatal ethanol exposure during late gestation (Experiment 1). After establishing the 
reliability of increased ethanol intake following prenatal exposure to the drug, a 
subsequent experiment tested kappa opioid mediation of this phenomenon (Experiment 
2). The possibility of prenatal ethanol affecting the motivational properties of both kappa 
and mu opioid signaling was then tested in Experiment 3 & 4, via second order 
conditioned place preference (Pautassi et al., 2011; 2012). 
 
2. Methods 
2.1. Subjects 
720 Sprague-Dawley male and female rat pups (postnatal day 14; PD14) 
representative of 90 litters, were employed in Experiments 1 through 5. The animals 
were PD14 at the start of the experimental procedures. All litters were born and reared at 
the Center for Development and Behavioral Neuroscience (Binghamton University, 
USA). Two females (at least PD60) were caged with a single male. For the following 
week vaginal smears were taken and the day of sperm detection was considered 
gestational day 0 (GD0). Births were examined daily and the day of parturition was 
considered as postnatal day 0 (PD 0). On PD1 litters were culled to 10 pups (5 males 
and 5 females, whenever possible). Pups were housed with the dam in standard 
maternity cages with free access to water and food. The colony was kept at 22 – 24 °C 
and a 12-hour light-dark cycle was used with light onset occurring at 700 AM. All 
procedures were in compliance with the Guide for Care and Use of Laboratory Animals 
(National Institutes of Health, 1986) and were also approved by the Institutional Animal 
Care and Use Committee within an AAALAC-accredited facility.  
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2.2. Prenatal Ethanol Treatment 
The procedures were similar to those used in Fabio et al., (2013) and in Díaz-
Cenzano & Chotro (2010). From gestational day 17 (GD17) to GD20 a randomly 
selected set of dams received daily intragastric (i.g) administrations of ethanol (12.6% 
v/v ethanol solution; volume of administration: 0.01 ml/g; dose: 1.0 g/kg); similar volume 
of vehicle (tap water), or remained untreated. Previous findings show this procedure 
results in fetuses achieving blood ethanol concentrations of approximately 50 mg/dl 
(Dominguez et al., 1998). Untreated dams were kept under similar housing conditions as 
the previous two groups but did not receive any treatment across GDs 17-20. 
 
2.3 Intraoral Cannulation 
Experiments 1 through 4 required cannulation for direct intraoral infusion of water 
or ethanol. A piece of polyethylene (PE)-10 tubing (Clay Adams, Parsippany, NJ), 3 cm in 
length, was flanged at one end using a heat source. The non-flanged end of the tubing 
was tightly fit onto one end of a sharpened and curved stainless-steel wire (0.285 mm 
diameter, approximately 4 cm in length). The wire was then inserted gently midline 
through the cheek, with the flanged tip resting anteriorly position on the interior portion of 
the cheek (Spear et al., 1989; Pautassi et al., 2002). The free end of the cannula was 
connected to PE-50 polyethylene tubing, which in turn was connected to a syringe 
placed in a 10-syringe infusion pump (KD Scientific, Holliston, MA). The size and 
schedule of the infusions was computer controlled. Unless stated otherwise, cannulation 
was performed 2 hr. prior to fluid infusion. 
 
2.4. Drug Preparation 
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Norbinaltorphimine (nor-BNI: selective kappa opioid antagonist: Experiment 2), 
Spiradoline mesylate (U62,066E: selective kappa opioid agonist: Experiment 3), and 
Tyr-d-Ala-Gly-N-Me-Phe-Gly-ol enkephalin (DAMGO: selective mu opioid agonist: 
Experiment 4) (Sigma-Aldrich, St. Louis, MO) were administered via intraperitoneal (i.p.) 
injections, as described in Nizhnikov et al., (2006b). Briefly, 30 gauge needles were 
used, connected to 1cc tuberculin syringes. The site of the injection was located 
approximately halfway between the diaphragm and the genitalia, on the right side of the 
pup. Injections were executed in less than 10s. Injection volume was 0.01 ml/g for all 
doses and saline (0.9%) was employed as the vehicle solution. Nor-BNI was 
administered 24 hours prior to the start of testing to allow for the drug effects to be 
selective for kappa opioid receptors (Metcalf and Coop, 2005). 
2.5. Infant Fluid Intake Test (Experiments 1 & 2) 
 The procedures were similar to those used in Chotro et al., (Chotro and Arias, 
2006) and Pautassi et al., (2012b). Specifically, two hours prior to each days’ intake test 
(Experiment 1: ethanol 5.0%, 10.0%, 20.0% or water; Experiment 2: ethanol 5.0% or 
water), pups were removed from the dam, cannulated (described above), and placed in 
pairs (1 male and 1 female) in a heated holding chamber. Each pair of animals received 
the same type of fluid infusions so that ethanol animals were never with water animals. 
Following the 2 hour acclimation period pups were voided by gentle brushing of the 
anogenital region and weighed to the nearest 0.01 g. Pups were given intraoral infusion 
of either ethanol or water (total volume: 5.5% of body weight, duration of infusion: 15 
min) in warmed, individual clear plastic chambers (8 cm × 8 cm × 25 cm). Previous 
studies indicate that these infusion parameters allow subjects to ingest or reject the fluid 
delivered at will (Pautassi et al., 2002). At the end of the test, subjects were removed, 
dried, weighed, had their cannula removed, and either returned to their dams 
(Experiment 1) or to a warmed holding cage for 2 hours (Experiment 2). Following the 2 
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hours the pups were returned to their dams overnight. Percent body weight gain of fluid 
ingested was calculated as follows: ((Pre-test Body Weight – Post-test Body Weight) / 
Pre-test Body Weight) * 100. 
 For Experiment 1 the test occurred on PD14 only. For Experiment 2 rat pups 
received a single i.p. injection with one of 3 doses of nor-BNI (0.0 (saline), 2.5 mg/kg, or 
10.0 mg/kg) on PD13 and were then immediately returned to their dam for 24 hours. The 
intake procedure as described above was then performed for 5 consecutive days 
starting on PD14. 
 
2.6. Second-order conditioning and testing (Experiments 3 & 4) 
Second-order conditioning (SOC), a variant of place conditioning, was conducted 
on postnatal days 14 (first-order conditioning) and 15 (test), as we have done previously 
(Pautassi et al., 2012b). SOC allows for the detection of ethanol’s appetitive or aversive 
effects across all ages (Molina et al., 2006; Pautassi et al., 2008, 2011), as well as the 
pharmacological dissection of these effects (Pautassi et al., 2011; 2012b). The 
procedure was composed of three phases (first-order conditioning, second-order 
conditioning, and testing): 
Phase 1 (first-order conditioning, PD 14): Pups were removed from their dam and 
placed in same-sex couples into a heated tub lined with pine shavings. Animals were 
immediately cannulated. A habituation phase was conducted 120 min. later, to induce 
familiarization with the conditioning chambers. Animals were weighed and then placed 
for 10 min into square Plexiglas chambers (10 x 10 x 12 cm) lined with cotton. The 
preweanlings were then administered U62,066E (0.0, 1.0, 5.0 or 10.0 mg/kg; Experiment 
3) or DAMGO (0.0, 0.1, 1.0 or 5.0 mg/kg; Experiment 4) and returned to their holding 
chambers. Conditioning started 5 or 30 minutes following the administration of U62,066E 
and DAMGO, respectively. The rationale for delaying conditioning with DAGMO up to 30 
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minutes was to allow the peptide to cross the blood-brain barrier; prior studies indicate 
that DAMGO enters the brain, albeit slowly [Kin (μl/(g × min) = 0.40 ± 0.55] (Van Dorpe 
et al., 2010). During the 15-min conditioning, which occurred in square Plexiglas 
chambers with cotton floors, the cheek PE-10 tubing was merged with the PE-50 tubing 
previously connected to an infusion pump (KD Scientific, Holliston, MA). The pump 
delivered the intraoral conditioned stimulus (CS1), which consisted of fifteen 5 s pulses 
(5 µl per pulse; interstimulus interval: 55 s) of distilled water. At termination of 
conditioning, the cheek cannula was removed and animals were placed into a warmed 
cage lined with wood shavings for 3 h, allowing metabolic processing of the kappa and 
mu agonists before reunion with dam and the rest of their littermates.  
Phase 2 (second-order conditioning, PD 15): Animals were cannulated and 
placed in a warmed cage for 60 min as we have previously done (Pautassi et al., 
2012b). Second-order conditioning then began by placing the subjects into square 
chambers similar to those during Phase 1; however, the floor was covered with 
sandpaper (50 grit; Gatorgrit, Fairborn, OH). The animals remained in these cages for 
four minutes and were given pairings of sandpaper (conditioned stimulus 2, CS2) and 
the distilled water CS1. Specifically, distilled water was intraorally infused every 55 s 
(volume: 5 µl; pulse duration: 5 s) for 4 min.  
Phase 3 (CPP test, PD 15): Thirty minutes after termination of Phase 2, animals 
were tested for CS2 preference in a two-way, 5 min tactile preference test. The test 
began by placing animals in a rectangular Plexiglas chamber (28  13  15.5 cm).  
floor of the chamber was split in two halves. One half was lined with sandpaper CS2 (50 
grit; Gatorgrit) and the other was lined with the smooth backside of a piece of 
sandpaper. Both textures were replaced after each test. Textures were selected based 
on previous experiments conducted in our lab that demonstrate their effectiveness in 
conditioning place preference experiments (e.g., Nizhnikov et al., 2009). An overhead 
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40-watt red bulb illuminated the room and time spent in each section of the apparatus 
was manually recorded in 1 min bins by an experimenter blind to the conditioning 
treatment. 
The intermediate section (15% of the entire surface) was considered a neutral 
area and not included for data gathering purposes. CS2 preference scores are 
expressed as the percent time spent on the rough sandpaper surface. Preference scores 
were calculated as follows: (total time spent over sandpaper) / (total time spent over 
sandpaper + total time spent over smooth)  100.  
2.7. Tissue Collection and Western Blot Analysis.  
 Two subjects (one male and one female) from each litter were not tested 
behaviorally but sacrificed via decapitation at PD14 and the brain was rapidly removed, 
flash frozen and stored at -80OC until further use. The nucleus accumbens (nAc), 
hippocampus, amygdala (AMYG), and prefrontal cortex (PFC) were microdissected and 
assessed due to their involvement in addiction processes, memory, anxiety, impulse 
control, and drug reinstatement. Tissue was processed to determine receptor expression 
levels in P2 synaptosomal preparations as described elsewhere (Werner et al., 2011; 
Santerre et al., 2013). Briefly, tissue was homogenized in 320 mM sucrose/phosphate 
buffered saline (PBS) solution and spun at low speed centrifugation (1,000 x g) and the 
subsequent supernatant was then spun again at 12,000 x g for 20 min. The resulting 
pellet (P2) was resuspended in PBS. Protein concentrations were quantified using a 
bicinchoninic acid method. Protein samples were subjected to SDS–polyacrylamide gel 
electrophoresis using Novex Tris–Glycine (8–16%) gels and transferred to 
polyvinylidene difluoride membranes (Invitrogen, Carlsbad, CA). Membranes were 
probed with a primary antibody for the kappa opioid receptor (Millipore, Billerica, MA) 
followed by appropriate secondary antibody (Thermo Scientific, Waltham, MA). Bands 
were detected using enhanced chemiluminescence (GE Healthcare, Amersham, UK) 
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and exposed to autoradiographic film under nonsaturating conditions. All membranes 
were reexposed to β-actin to control for loading. Densitometric analysis was conducted 
using NIH Image J software. All samples were assessed in duplicate to triplicate. 
 
2.8. Research Design and Data analysis 
 Significant main effects or interactions were examined through pair-wise post-hoc 
comparisons (Fisher’s Least Mean Significant tests, alpha level set at 0.05). Experiment 
1 assessed ethanol intake via a two way Analyses of Variance (ANOVA) and consisted 
of a 2 (sex) x 3 (Prenatal Treatment) x 4 (Ethanol concentrations) factorial design. 
Experiment  2  analyzed data via a repeated measures ANOVA and consisted of a 2 
(sex) x 3 (Prenatal Treatment) x 3 (nor-BNI dose) design. Experiment 3 consisted of a 2 
(sex) x 5 (U62,066 dose) design. Experiment 4 used a 2 (sex) x 5 (DAMGO dose) 
design. Both experiment 3 and 4 used a two way ANOVA to analyze results. Finally, 
Experiment 5 analyzed kappa opioid receptor expression following 2 prenatal treatments 
in 4 brain regions and utilized a Student’s t-test to compare untreated and prenatally 
ethanol exposed subjects, since preliminary experiments indicated no differences in 
kappa opioid expression or ethanol intake between untreated and prenatally water 
exposed subjects in Experiment 1. 
The dependent variables were ethanol and water intake (percent body weight 
gain, %BWG; Experiments 1 and 2), and percent time spent over the sandpaper texture 
(Experiments 3 and 4). Kappa opioid receptor expression in specific brain regions was 
the dependent variable for Experiment 5.  
In order to avoid overrepresentation of litters within each specific group, no more 
than 2 animals per litter (one male and one female) were assigned to each particular 
treatment. Sex was also considered as a factor; however, since this variable failed to 
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exert significant main effects or interact with the remaining factors in all experiments, 
data were collapsed across this variable. 
 
3. Results 
3.1. Experiment 1: Prenatal ethanol exposure increases subsequent ethanol intake. 
Experiment 1 assessed intake of several concentrations of ethanol or water in 
PD14 subjects as a function of prenatal treatment (percent body weight gain used as a 
measure of fluid intake). Analysis revealed main effects of fluid F(3, 88) = 40.12, p < 
0.0001, and prenatal treatment F(2, 88) = 3.89, p < 0.05, as well as a fluid x prenatal 
treatment interaction F(6, 88) = 3.20, p < 0.01. All subjects drank less 20% ethanol than 
any other fluid. However, animals experiencing prenatal ethanol drank more 5.0% 
ethanol than any other prenatal condition group, which did not differ from each other 
(Figure 1). No other differences in fluid intake were seen as a function of prenatal 
treatment. It seems that the prenatal ethanol exposure protocol used here, albeit much 
briefer than  the one employed in other studies (e.g., Zhou et al., 2003), reliably 
promotes ethanol intake of a moderately (i.e., 5.0 % v/v) concentrated solution, without 
altering overall patterns of fluid intake.  
 
[Insert Figure 1 about here] 
 
3.2. Experiment 2: Kappa opioid receptor activity mediates ethanol intake in controls but 
not in animals prenatally exposed to ethanol. 
In Experiment 2 the effects of nor-BNI pretreatment (kappa opioid antagonist) on 
intake of ethanol or water across 5 days was analyzed as a function of prenatal 
treatment. As 5% ethanol concentration elicited robust increases in ethanol intake 
following prenatal ethanol exposure, this concentration was used for Experiment 2. 
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Preliminary analysis of animals injected with saline on PD13 revealed a main 
effect of prenatal treatment (F(2, 26) = 11.48, p < 0.001). Similar to Experiment 1, 
Animals exposed to ethanol prenatally exhibited higher ethanol consumption than the 
remaining conditions. In view of these baseline differences in ethanol intake and 
following the statistical approach employed by Varlinskaya and Spear (2012), 
subsequent analyses were conducted separately based on prenatal treatment.  
The ANOVA for prenatally untreated animals indicated a main effect of nor-BNI 
F(2, 100) = 5.03, p < 0.02, days F(4, 100) = 4.19, p < 0.01 and a nor-BNI x testing day 
interaction F(8, 100) = 2.61, p < 0.02. Further analysis indicated a slight, but significant, 
increase in ethanol intake on day 1 for animals given the 10 mg/kg nor-BNI dose (se  
Figure 2). Animals given both doses of nor-BNI exhibited significantly greater ethanol 
intake on days 4 and 5 than animals treated with 0.0 mg/kg nor-BNI. 
For prenatally water treated animals, the analysis yielded a main effect of testing day 
F(4, 120) = 9.70, p < 0.0001; as well as a nor-BNI x testing day interaction F(8, 120) = 
2.07, p < 0.05. Further analysis indicated that the 2.5 mg/kg nor-BNI dose slightly, but 
significantly, increased ethanol intake on day 1 of testing. However, a more robust 
significant increase in ethanol intake following 2.5 mg/kg nor-BNI administration was 
seen on day 5 (Figure 3). A borderline effect was also observed for the 10 mg/kg dose 
at both days 1 and 5, but neither reached the level of significance. 
 The ANOVA for subjects treated prenatally with ethanol only revealed a main 
effect of testing day (F(4, 112) = 7.07, p < 0.0001). Ethanol intake was lower on day 2 
than on any other test day and this pattern was similar in subjects given either dose of 
nor-BNI or vehicle (Figure 4).  
Overall, the results from this experiment indicate that the antagonism of kappa 
opioid receptors results in increased ethanol intake in control animals, particularly after 
repeated exposure to ethanol. This effect may be due to an attenuation of the aversive 
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effects of ethanol. Perhaps a more important result was that prenatal ethanol made 
animals insensitive to this kappa-mediation of ethanol intake.  
 
[Insert Figure 2 about here] 
 
3.3. Experiment 3: Changes in responding to kappa (U62,066) opioid stimulation as a 
function of prenatal ethanol exposure. 
Analysis for time spent in contact with the sandpaper CS2 yielded a main effect 
of U62 treatment (F4,188 = 2.63, p < 0.05) as well as a U62 treatment x prenatal ethanol 
interaction (F8,188 = 2.56, p < 0.05). Further analyses revealed that prenatal vehicle and 
prenatal untreated animals given the higher dose of the kappa agonist (10 mg/kg) spent 
less time on sandpaper than vehicle or untreated controls. This pattern of results, 
depicted in Figure 5, is indicative of U62-induced conditioned place avoidance. 
Furthermore, untreated animals also found the moderate dose of U62 (5.0 mg/kg) 
aversive. The post-hocs provided no indication of conditioned place avoidance in 
prenatally ethanol exposed pups. On the contrary, pups given ethanol in-utero and 
conditioned with 5 mg/kg U62 exhibited greater time spent on the sandpaper than 
untreated and vehicle-treated counterparts did.  
This experiment indicates that prenatal ethanol may significantly alter the 
motivational tone of the endogenous kappa opioid system. Activation of this system 
induces, as expected, conditioned place avoidance in the offspring of control dams. 
Prenatal ethanol disrupted the expression of this conditioned avoidance and even made 
animals prefer the kappa-related texture, when the 5 mg/kg dose was employed. 
 
3.4. Experiment 4: Changes in responding to mu (DAMGO) opioid stimulation as a 
function of prenatal ethanol exposure.  
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Experiment 3 revealed that prenatal ethanol alters the sensitivity to the 
motivational consequences of KOR activation, an effect that may underlie the greater 
ethanol intake after prenatal exposure. Effects of prenatal exposure on the endogenous 
opioid system may be, however, broader, affecting functionality of mu receptors. 
Experiment 4 assessed second-order conditioned place preference/aversion, induced by 
the administration of the mu agonist DAMGO.  
The ANOVA for percent time spent in the DAMO-related sandpaper, indicated 
the lack of significant main effects for prenatal exposure or DAMGO treatment. No 
significant interactions were observed (see Figure 6). 
These results, taken together with those derived from Experiment 3, indicate that 
the effects of prenatal ethanol exposure, at this age, may be more dependent on 
changes on kappa than on mu opioid receptor function. 
 
Insert Figures 3 and 4 about here 
 
3.5. Experiment 5: Changes in kappa opioid receptor expression as a function of 
prenatal ethanol exposure. 
 Given the involvement of kappa opioid receptors in ethanol intake and the 
observed changes in preference for kappa opioid activation following prenatal ethanol 
exposure, we wanted to assess whether kappa opioid expression correlated with the 
behavioral responses. Compared to controls, we found that prenatal ethanol exposure 
reduced synaptosomal kappa opioid receptor expression in the nucleus accumbens by 
41.6% (t = 2.494, p < 0.05, Figure 7A), as well as in the amygdala by 47.9% (t = 2.606, 
p < 0.05, Figure 7B) and hippocampus by 52.5% (t = 3.259, p < 0.01, Figure 7C). No 
differences were found for the prefrontal cortex (Figure 7D). 
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Insert Figure 5 about here 
 
4.0. Discussion: 
The current set of experiments tested the effects of brief prenatal exposure to 
physiologically relevant doses of ethanol during late gestation on ethanol intake, kappa 
opioid involvement in ethanol intake, and changes in kappa opioid function and 
expression.  
The results indicate that relatively low prenatal ethanol exposure significantly 
increased drinking of 5.0% ethanol solution and decreased sensitivity to modulation of 
ethanol drinking by kappa opioid antagonists. Most strikingly, while control animals 
developed conditioned place aversions to textures paired with kappa agonists, 
experience with ethanol in the womb resulted in appetitive or neutral responding to 
kappa agonists. Changes in motivational responding after prenatal ethanol were specific 
to the kappa system, since no change was seen in response to a mu agonist.  
 
Changes in preference for kappa opioid receptor activation were accompanied by 
a significant down regulation of kappa opioid receptor expression in brain regions critical 
for ethanol responding such as the nucleus accumbens, hippocampus, and amygdala. 
These results are especially intriguing since the specific brain areas affected by prenatal 
ethanol have been implicated in responding for ethanol. This set of results is consistent 
with previous work indicating that prenatal ethanol significantly enhances sensitivity to 
ethanol-induced appetitive effects, reduces sensitivity to ethanol-induced aversion 
(Pautassi et al., 2012a), and reduces baseline level of activation in the infralimbic area 
(Fabio et al., 2013).  
Increased intake of ethanol following prenatal exposure has been shown in the 
past, and this effect lasts into adolescence (i.e., Diaz-Cenzano and Chotro, 2010; Fabio 
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et al., 2013). However, a thorough analysis of acceptance of different concentrations 
following prenatal ethanol exposure has been lacking. Our findings indicate that prenatal 
exposure to 1.0 g/kg ethanol during gestational days 17-20 increases the intake of 5.0% 
but not 10.0% or 20.0% ethanol solution in PD14 rat pups (Experiment 1). 
One possible reason for the increased intake is a change in the pharmacological 
reinforcing properties of ethanol following prenatal exposure. We have previously shown 
that animals experiencing ethanol prenatally find higher doses of ethanol reinforcing 
compared to controls (Nizhnikov et al., 2006a; Pautassi et al., 2012b). Similarly, in the 
present study changes in the reinforcing properties of a selective kappa agonist were 
attributed to prenatal ethanol. Control subjects found kappa opioid activation aversive, a 
result that was expected given that activation of the kappa opioid system has been 
shown to mediate the aversive properties of stress (Land et al., 2009) and that kappa 
agonists are aversive for adult animals (Mucha and Herz, 1985; Shippenberg and Herz, 
1986; Bals-Kubik et al., 1989). Conversely, animals prenatally exposed to alcohol 
formed either preference for a texture paired with a kappa agonist or did not form an 
aversion (Experiment 3). This set of results suggests that prenatal ethanol induces a 
change in the function of the kappa opioid system. 
The results of Experiment 4 with DAMGO were surprising given previous work 
showing conditioned place preference to central administration of this selective mu 
agonist (Bals-Kubik et al., 1993; Madhavan et al., 2010). However, differences in the 
route of administration, timing, and age of conditioning likely contribute to the differences 
between the above listed studies and ours. Alternatively, DAMGO may have affected the 
perception of the CS during the initial conditioning phase.  
The kappa opioid system is of special interest with regard to prenatal ethanol 
exposure partly because of an established functional switch during normal ontogeny. In 
early infancy, activation of the kappa system is appetitive (Varlinskaya et al., 1996; 
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Petrov et al., 2006), whereas later in development kappa agonists induce aversion 
(Mucha and Herz, 1985; Shippenberg and Herz, 1986; Bals-Kubik et al., 1989). Given 
the kappa system’s established involvement in ethanol’s aversive and dysphoric effects 
during late infancy and adulthood in non-dependent rats (Matsuzawa et al., 1999; 
Mitchell et al., 2005; Logrip et al., 2009), perturbation of this system during a particularly 
sensitive and critical developmental period may lead to changes in responding to alcohol 
later in life. Specifically, disruption of the kappa system may reduce the aversive 
properties of ethanol later in life, leading to increased propensity for use and abuse of 
ethanol. The present findings indicate that the switch in kappa opioid function (from 
appetitive to aversive) may be either delayed or reversed following prenatal ethanol 
exposure.  
One possible explanation for the alteration in motivational sensitivity to kappa 
activation is that prenatal ethanol changes the expression of kappa opioid receptors in 
brain regions intimately related to ethanol responding. We found that kappa opioid 
receptor expression was decreased in the nucleus accumbens, amygdala, and 
hippocampus, but not the prefrontal cortex. Changes to opioid receptor expression 
following exposure to ethanol are not surprising in view of evidence that opioid peptides 
and receptors are altered following chronic alcohol exposure (Gianoulakis, 1996; 
Turchan et al., 1999; Chen and Lawrence, 2000; Lindholm et al., 2001). In fact, ethanol 
exposure has been shown to influence the kappa opioid system specifically. For 
example, Rosin et al., (1999) reported that chronic ethanol exposure up-regulates kappa 
mRNA levels. Such effects are also suggested by behavioral tests showing that a kappa 
opioid antagonist blocks increased ethanol intake only in alcohol-dependent animals 
(Walker and Koob, 2008). Taken together, these findings suggest an up-regulation of 
kappa opioid receptor expression due to prolonged ethanol exposure.  
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In the present work, decreased kappa expression following low levels of ethanol 
exposure seems to contribute to increased ethanol intake. While the underlying 
mechanisms for these effects are not clear at present, the previously identified 
developmental switch in kappa opioid receptor function during early development may 
be involved. These effects may also depend upon dose and duration of ethanol 
exposure. Potentially, specific cellular mechanisms such as associations with G proteins 
may underlie developmental and prenatal ethanol exposure effects. Furthermore, the 
persistence of reductions in kappa opioid function and expression needs to be 
investigated.  
It is likely that trafficking of synaptosomal kappa opioid receptors also plays a 
major role in these effects of ethanol on the kappa opioid system, as has been shown for 
other receptors following ethanol exposure (reviewed in: Kumar et al., 2009). In 
particular, unpublished observations from our group indicate that total kappa opioid 
receptor expression in the nucleus accumbens following the same prenatal ethanol dose 
used here, albeit on prenatal day 12, displayed differences from controls. Although total 
expression needs to be further validated at the prenatal exposure age used here, 
together with the present results, this suggests that prenatal ethanol exposure might 
arrest synaptosomal trafficking mechanisms. Also, it is possible that the effects seen in 
this set of experiments persists into adolescence or even adulthood. Nonetheless, this is 
the first time that prenatal exposure at such low, albeit physiologically relevant, ethanol 
levels have been shown to exert such profound effects on kappa opioid function and 
expression.  
While the current work focuses on the contributions of kappa opioid receptors, 
other opioid systems should also be assessed and contributions of non-opioid systems 
such as GABA and glutamate should be explored in the present context. While the limbic 
system has been a major focus, we cannot rule out changes in ethanol taste preference, 
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as previous results indicate increased ethanol palatability following prenatal ethanol 
exposure (Arias and Chotro, 2005; Youngentob and Glendinning, 2009; Glendinning et 
al., 2012).  
Our previous work indicates that the doses used in the present studies do not 
produce changes in placenta weight, umbilical cord length, offspring's body weights, 
weights and/or size of the olfactory bulbs, cerebral hemispheres, and cerebellum or the 
granular layer of the olfactory bulb (Dominguez et al., 1998; Pueta et al., 2011). 
However, we cannot rule out that these low levels of prenatal ethanol exposure may 
produce other molecular teratological effects. Alternatively, these animals could have 
experienced difficulty learning. However, such a possibility is unlikely, given previous 
evidence that the present prenatal ethanol treatment does not preclude learning 
(Nizhnikov et al., 2006a; Pautassi et al., 2012b). Additionally, the animals in the present 
study readily displayed learned preference for a texture paired with a kappa agonist and 
were therefore capable of conditioning.   
In conclusion, the results presented here add to a growing literature indicating 
increased ethanol intake following prenatal ethanol exposure (see: Spear and Molina, 
2005) and highlight limbic kappa opioid receptor involvement in the effects of prenatal 
ethanol exposure on ethanol intake later in life. 
 
REFERENCES: 
Alati R, Al Mamun A, Williams GM, O'Callaghan M, Najman JM, Bor W (2006) In 
utero alcohol exposure and prediction of alcohol disorders in early adulthood: a 
birth cohort study. Arch Gen Psychiatry 63:1009-1016. 
Alati R, Clavarino A, Najman JM, O'Callaghan M, Bor W, Mamun AA, Williams GM 
(2008) The developmental origin of adolescent alcohol use: findings from the 
 24 
 
Mater University Study of Pregnancy and its outcomes. Drug and alcohol 
dependence 98:136-143. 
Arias C, Chotro MG (2005) Increased preference for ethanol in the infant rat after 
prenatal ethanol exposure, expressed on intake and taste reactivity tests. Alcohol 
Clin Exp Res 29:337-346. 
Baer JS, Barr HM, Bookstein FL, Sampson PD, Streissguth AP (1998) Prenatal alcohol 
exposure and family history of alcoholism in the etiology of adolescent alcohol 
problems. J Stud Alcohol 59:533-543. 
Baer JS, Sampson PD, Barr HM, Connor PD, Streissguth AP (2003) A 21-year 
longitudinal analysis of the effects of prenatal alcohol exposure on young adult 
drinking. Arch Gen Psychiatry 60:377-385. 
Bals-Kubik R, Herz A, Shippenberg TS (1989) Evidence that the aversive effects of 
opioid antagonists and kappa-agonists are centrally mediated. 
Psychopharmacology (Berl) 98:203-206. 
Bals-Kubik R, Ableitner A, Herz A, Shippenberg TS (1993) Neuroanatomical sites 
mediating the motivational effects of opioids as mapped by the conditioned place 
preference paradigm in rats. J Pharmacol Exp Ther 264:489-495. 
Barson JR, Carr AJ, Soun JE, Sobhani NC, Rada P, Leibowitz SF, Hoebel BG (2010) 
Opioids in the hypothalamic paraventricular nucleus stimulate ethanol intake. 
Alcohol Clin Exp Res 34:214-222. 
Chen F, Lawrence AJ (2000) Effect of chronic ethanol and withdrawal on the mu-opioid 
receptor- and 5-Hydroxytryptamine(1A) receptor-stimulated binding of 
 25 
 
[(35)S]Guanosine-5'-O-(3-thio)triphosphate in the fawn-hooded rat brain: A 
quantitative autoradiography study. J Pharmacol Exp Ther 293:159-165. 
Chotro MG, Arias C (2006) Exposure to low and moderate doses of alcohol on late 
gestation modifies infantile response to and preference for alcohol in rats. Annali 
dell'Istituto superiore di sanita 42:22-30. 
Cowen MS, Lawrence AJ (2001) Alterations in central preproenkephalin mRNA 
expression after chronic free-choice ethanol consumption by fawn-hooded rats. 
Alcohol Clin Exp Res 25:1126-1133. 
Diaz-Cenzano E, Chotro MG (2010) Prenatal binge ethanol exposure on gestation days 
19-20, but not on days 17-18, increases postnatal ethanol acceptance in rats. 
Behav Neurosci 124:362-369. 
Dominguez HD, Lopez MF, Molina JC (1998) Neonatal responsiveness to alcohol odor 
and infant alcohol intake as a function of alcohol experience during late gestation. 
Alcohol 16:109-117. 
Eade AM, Youngentob SL (2010) The interaction of gestational and postnatal ethanol 
experience on the adolescent and adult odor-mediated responses to ethanol in 
observer and demonstrator rats. Alcohol Clin Exp Res 34:1705-1713. 
Fabio MC, March SM, Molina JC, Nizhnikov ME, Spear NE, Pautassi RM (2013) 
Prenatal ethanol exposure increases ethanol intake and reduces C-fos expression 
in infralimbic cortex of adolescent rats. Pharmacol Biochem Behav 103:842-852. 
Gianoulakis C (1996) Implications of endogenous opioids and dopamine in alcoholism: 
human and basic science studies. Alcohol Alcohol Suppl 1:33-42. 
 26 
 
Glendinning JI, Simons YM, Youngentob L, Youngentob SL (2012) Fetal ethanol 
exposure attenuates aversive oral effects of TrpV1, but not TrpA1 agonists in rats. 
Exp Biol Med (Maywood) 237:236-240. 
Kato H (2008) [Pharmacological effects of a mu-opioid receptor antagonist naltrexone on 
alcohol dependence]. Nihon Arukoru Yakubutsu Igakkai zasshi = Japanese 
journal of alcohol studies & drug dependence 43:697-704. 
Kumar S, Porcu P, Werner DF, Matthews DB, Diaz-Granados JL, Helfand RS, Morrow 
AL (2009) The role of GABA(A) receptors in the acute and chronic effects of 
ethanol: a decade of progress. Psychopharmacology (Berl) 205:529-564. 
Land BB, Bruchas MR, Schattauer S, Giardino WJ, Aita M, Messinger D, Hnasko TS, 
Palmiter RD, Chavkin C (2009) Activation of the kappa opioid receptor in the 
dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug 
seeking. Proc Natl Acad Sci U S A 106:19168-19173. 
Lindholm S, Werme M, Brene S, Franck J (2001) The selective kappa-opioid receptor 
agonist U50,488H attenuates voluntary ethanol intake in the rat. Behav Brain Res 
120:137-146. 
Logrip ML, Janak PH, Ron D (2009) Blockade of ethanol reward by the kappa opioid 
receptor agonist U50,488H. Alcohol 43:359-365. 
Madhavan A, Bonci A, Whistler JL (2010) Opioid-Induced GABA potentiation after 
chronic morphine attenuates the rewarding effects of opioids in the ventral 
tegmental area. J Neurosci 30:14029-14035. 
 27 
 
Matsuzawa S, Suzuki T, Misawa M, Nagase H (1999) Different roles of mu-, delta- and 
kappa-opioid receptors in ethanol-associated place preference in rats exposed to 
conditioned fear stress. Eur J Pharmacol 368:9-16. 
Mendez M, Morales-Mulia M (2008) Role of mu and delta opioid receptors in alcohol 
drinking behaviour. Current drug abuse reviews 1:239-252. 
Metcalf MD, Coop A (2005) Kappa opioid antagonists: past successes and future 
prospects. The AAPS journal 7:E704-722. 
Mitchell JM, Liang MT, Fields HL (2005) A single injection of the kappa opioid 
antagonist norbinaltorphimine increases ethanol consumption in rats. 
Psychopharmacology (Berl) 182:384-392. 
Molina JC, Ponce LF, Truxell E, Spear NE (2006) Infantile sensitivity to ethanol's 
motivational effects: Ethanol reinforcement during the third postnatal week. 
Alcohol Clin Exp Res 30:1506-1519. 
Mucha RF, Herz A (1985) Motivational properties of kappa and mu opioid receptor 
agonists studied with place and taste preference conditioning. 
Psychopharmacology (Berl) 86:274-280. 
Nizhnikov ME, Molina JC, Varlinskaya EI, Spear NE (2006a) Prenatal ethanol exposure 
increases ethanol reinforcement in neonatal rats. Alcohol Clin Exp Res 30:34-45. 
Nizhnikov ME, Varlinskaya EI, Petrov ES, Spear NE (2006b) Reinforcing properties of 
ethanol in neonatal rats: involvement of the opioid system. Behav Neurosci 
120:267-280. 
 28 
 
Nizhnikov ME, Pautassi RM, Truxell E, Spear NE (2009) Opioid antagonists block the 
acquisition of ethanol-mediated conditioned tactile preference in infant rats. 
Alcohol 43:347-358. 
Pautassi RM, Godoy JC, Spear NE, Molina JC (2002) Early responsiveness to stimuli 
paired with different stages within the state of alcohol intoxication. Alcohol Clin 
Exp Res 26:644-654. 
Pautassi RM, Nizhnikov ME, Acevedo MB, Spear NE (2012a) Early role of the kappa 
opioid receptor in ethanol-induced reinforcement. Physiol Behav 105:1231-1241. 
Pautassi RM, Nizhnikov ME, Spear NE, Molina JC (2012b) Prenatal ethanol exposure 
leads to greater ethanol-induced appetitive reinforcement. Alcohol 46:585-593. 
Pautassi RM, Myers M, Spear LP, Molina JC, Spear NE (2008) Adolescent but not adult 
rats exhibit ethanol-mediated appetitive second-order conditioning. Alcohol Clin 
Exp Res 32:2016-2027. 
Pautassi RM, Myers M, Spear LP, Molina JC, Spear NE (2011) Ethanol induces second-
order aversive conditioning in adolescent and adult rats. Alcohol 45:45-55. 
Petrov ES, Nizhnikov ME, Varlinskaya EI, Spear NE (2006) Dynorphin A (1-13) and 
responsiveness of the newborn rat to a surrogate nipple: immediate behavioral 
consequences and reinforcement effects in conditioning. Behav Brain Res 170:1-
14. 
Pettinati HM, O'Brien CP, Rabinowitz AR, Wortman SP, Oslin DW, Kampman KM, 
Dackis CA (2006) The status of naltrexone in the treatment of alcohol 
dependence: specific effects on heavy drinking. Journal of clinical 
psychopharmacology 26:610-625. 
 29 
 
Pueta M, Rovasio RA, Abate P, Spear NE, Molina JC (2011) Prenatal and postnatal 
ethanol experiences modulate consumption of the drug in rat pups, without 
impairment in the granular cell layer of the main olfactory bulb. Physiol Behav 
102:63-75. 
Rosin A, Lindholm S, Franck J, Georgieva J (1999) Downregulation of kappa opioid 
receptor mRNA levels by chronic ethanol and repetitive cocaine in rat ventral 
tegmentum and nucleus accumbens. Neurosci Lett 275:1-4. 
Santerre JL, Gigante ED, Landin JD, Werner DF (2013) Molecular and behavioral 
characterization of adolescen protein kinase C following high dose ethanol 
exposure. Psychopharmacology (Berl) In Press. 
Shippenberg TS, Herz A (1986) Differential effects of mu and kappa opioid systems on 
motivational processes. NIDA research monograph 75:563-566. 
Sommer W, Hyytia P, Kiianmaa K (2006) The alcohol-preferring AA and alcohol-
avoiding ANA rats: neurobiology of the regulation of alcohol drinking. Addict 
Biol 11:289-309. 
Spear LP, Specht SM, Kirstein CL, Kuhn CM (1989) Anterior and posterior, but not 
cheek, intraoral cannulation procedures elevate serum corticosterone levels in 
neonatal rat pups. Developmental psychobiology 22:401-411. 
Spear NE, Molina JC (2005) Fetal or infantile exposure to ethanol promotes ethanol 
ingestion in adolescence and adulthood: a theoretical review. Alcohol Clin Exp 
Res 29:909-929. 
Turchan J, Przewlocka B, Toth G, Lason W, Borsodi A, Przewlocki R (1999) The effect 
of repeated administration of morphine, cocaine and ethanol on mu and delta 
 30 
 
opioid receptor density in the nucleus accumbens and striatum of the rat. 
Neuroscience 91:971-977. 
Van Dorpe S, Adriaens A, Polis I, Peremans K, Van Bocxlaer J, De Spiegeleer B (2010) 
Analytical characterization and comparison of the blood-brain barrier 
permeability of eight opioid peptides. Peptides 31:1390-1399. 
Varlinskaya EI, Petrov ES, Smotherman WP (1996) Classical conditioning in the fetal 
rat: reinforcing properties of dynorphin A (1-13). Behav Neurosci 110:154-167. 
Walker BM, Koob GF (2008) Pharmacological evidence for a motivational role of kappa-
opioid systems in ethanol dependence. Neuropsychopharmacology 33:643-652. 
Werner DF, Kumar S, Criswell HE, Suryanarayanan A, Fetzer JA, Comerford CE, 
Morrow AL (2011) PKCgamma is required for ethanol-induced increases in 
GABA(A) receptor alpha4 subunit expression in cultured cerebral cortical 
neurons. J Neurochem 116:554-563. 
Youngentob SL, Glendinning JI (2009) Fetal ethanol exposure increases ethanol intake 
by making it smell and taste better. Proc Natl Acad Sci U S A 106:5359-5364. 
Zapata A, Shippenberg TS (2006) Endogenous kappa opioid receptor systems modulate 
the responsiveness of mesoaccumbal dopamine neurons to ethanol. Alcohol Clin 
Exp Res 30:592-597. 
 
 
Atalli B, Saya D, Vogen Z (1990) Pre-and postnatal development of opiate recaeptor 
subtypes in rat spinal cord.  Brain Res 53: 97-102. 
 
Leslie FM, Loughlin, SE (1992) Development of multiple opioid receptors. In Miller MW 
(ed), Development of the Central Nervous System: Effects of Alcohol and 
Opiates. NY: Wiley-Liss, 255. 
 31 
 
Leslie ML, Loughlin SE (1993). Ontogeny and plasticity of opioid systems. In Hammer 
RP. (Eds.), The Neurobiology of Opiates (pp. 85-123). Boca Raton, FL, USA: 
CRC Press, Inc. 408 pp. 
 
Petrillo P, Tavani A, Verotta D, Robson LE, Kosterlitz HW (1987) Differential postnatal 
development of mu-, delta- and kappa-opioid binding sites in rat brain. Brain Res 
428: 53-58. 
 
Fabio MC, March SM, Molina JC, Nizhnikov ME, Spear NE, Pautassi RM. (2013)  
Prenatal ethanol exposure increases ethanol intake and reduces C-fos 
expression in infralimbic cortex of adolescent rats.  Pharmacol Biochem Behav. 
103(4):842-52.  
 
Abate P, Varlinskaya EI, Cheslock SJ, Spear NE, Molina JC. (2002). Neonatal activation 
of alcohol-related prenatal memories: impact on the first suckling response. 
Alcohol Clin Exp Res. 26(10):1512-22. 
 
Abate P, Pepino MY, Spear NE, Molina JC. (2004). Fetal learning with ethanol: 
correlations between maternal hypothermia during pregnancy and neonatal 
responsiveness to chemosensory cues of the drug. Alcohol Clin Exp Res. 
28(5):805-15. 
 
Miranda-Morales RS, Molina JC, Spear NE, Abate P. (2010). Participation of the 
endogenous opioid system in the acquisition of a prenatal ethanol-related 
memory: effects on neonatal and preweanling responsiveness to ethanol. Physiol 
Behav. 4;101(1):153-60. 
 
Zhou FC, Sari Y, Powrozek T, Goodlett CR, Li TK. (2003). Moderate alcohol exposure 
compromises neural tube midline development in prenatal brain. Brain Res Dev 
Brain 144(1):43-55. 
 
Zhou FC, Sari Y, Powrozek T, Goodlett CR, Li TK. (2003). Moderate alcohol exposure 
compromises neural tube midline development in prenatal brain. Brain Res Dev 
Brain Res. 144(1):43-55. 
 
Varlinskaya EI, Spear LP. (2012). Increases in anxiety-like behavior induced by acute 
stress are reversed by ethanol in adolescent but not adult rats. Pharmacol 
Biochem Behav. 100(3):440-50. 
 32 
 
Figure Captions: 
Figure 1. Drinking of several concentrations of ethanol (percentage of body weight gain, 
% BWG) as a function of prenatal ethanol treatment (0.0, 1.0 g/kg or no treatment) is 
presented. Vertical bars depict means ± S.E.M. The results indicate a significant 
increase in drinking of 5.0% ethanol in subjects exposed to ethanol prenatally compared 
to controls (F(2,88) = 3.89, p <0.05). Asterisk indicates a significant difference in a given 
group from water controls. 
 
Figure 2. Drinking of 5.0% ethanol (percentage of body weight gain, % BWG) as a 
function of pretreatment with a kappa opioid antagonist (nor-BNI) in pups derived from 
untreated (panel A), prenatally water (panel B), or prenatally ethanol (panel C) treated 
dams across 5 days of testing is depicted as means ± S.E.M. The kappa opioid 
antagonist nor-BNI was given 24 hours prior to testing). The results indicate a significant 
increase in ethanol intake in prenatally untreated subjects for subjects receiving the high 
dose of nor-BNI on day 1 and both doses on days 4 and 5 (F(2,100) = 5.03, p<0.02). 
Analysis for prenatally water treated animals indicated that the 2.5 mg/kg nor-BNI dose 
slightly, but significantly, increased ethanol intake on day 1 of testing. However, a more 
robust significant increase in ethanol intake following 2.5 mg/kg nor-BNI administration 
was seen on day 5, F(8, 120) = 2.07, p < 0.05. For prenatally ethanol treated subjects no 
effect of nor-BNI was seen.  Asterisk indicates a significant difference from water 
controls. 
 
Figure 3. Percent time spent on a conditioned stimulus (CS+, a sandpaper texture) 
associated with the effects of a kappa opioid agonist (U62,066E), as a function of 
prenatal treatment (0.0, 1.0 g/kg ethanol, or no treatment) and U62,066E dose (0.0, 1.0, 
5.0 or 10.0 mg/kg; or untreated). The results indicate a significant drug x prenatal 
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treatment interaction (F(4, 188) = 2.63, p<0.05). Control subjects (untreated, prenatal 
water) displayed aversion to the effects of 5.0 or 10.0 mg/kg U62,066E, while prenatally 
ethanol treated pups showed no aversion and even preference for the 5.0 mg/kg dose. 
Percent time spent in the CS+ is depicted as means ± S.E.M. 
 
Figure 4. Percent time spent on a conditioned stimulus (CS+, a sandpaper texture) 
associated with the effects of a mu opioid agonist (DAMGO), as a function of prenatal 
treatment (0.0, 1.0 g/kg or no treatment) and DAMGO dose (0.0, 0.1, 1.0 or 5.0 mg/kg; 
or untreated). The results indicate no significant main effects or interactions. Percent 
time spent on the CS+ is depicted as means ± S.E.M. 
 
Figure 5. Synaptosomal kappa opioid expression following prenatal ethanol exposure in 
the nucleus accumbens (NAc) (A), amygdala (B), hippocampus (C), and prefrontal 
cortex (PFC) (D). The results indicate that prenatal ethanol exposure reduced 
synaptosomal kappa opioid expression 41-52% in the nucleus accumbens, amygdala 
and hippocampus. The prefrontal cortex was unaffected. Representative blots are shown 
for each region. Data is presented as mean ± S.E.M. * p < 0.05, n = 5-8 per group. 
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